Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers

Completed · Not applicable

Conditions studied: Healthy

In brief

RATIONALE: Lorazepam, diphenhydramine hydrochloride, and haloperidol gel, when absorbed into the skin, may be an effective treatment for nausea and vomiting.PURPOSE: This clinical trial studies lorazepam, diphenhydramine hydrochloride, and haloperidol gel in healthy volunteers.

Key facts

Study ID

NCT01204255

Run by

Virginia Commonwealth University

People needed

11

Starts

2010-11-15

Expected to finish

2011-05-17

Last updated by the study team

2017-11-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Completed a medical screening questionnaire
• English speaking
• No allergies to the drugs
• Able to complete the forms
• If a woman of childbearing age, agree to use contraception

You may not qualify if…

• History of substance abuse, psychiatric disorder, acquired brain injury, the possibility of pregnancy (not using birth control, and of child bearing age)
• Use of any medication that would contraindicate benzodiazepine administration
• Pregnant or nursing

Where it is running

• Virginia Commonwealth University/Massey Cancer Center — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.